miR Scientific, LLC | 1 395 abonnés sur LinkedIn. miR Scientific is a healthcare company that is committed to transforming cancer management globally. | miR Scientific, LLC is a healthcare company committed to transforming global cancer management by providing early and highly accurate detection, characterization, and monitoring of disease. The Company has developed the miR Disease Management Platform®, a proprietary, non-invasive platform for the effective management of targeted diseases, initially focused on urological cancers. The platform is powered by the miR Sentinel® Prostate Cancer Test, a liquid biopsy urine test that can accurately detect, classify, and monitor prostate cancer based on the interrogation of small-non-coding RNAs extracted from urinary exosomes. miR Scientific is developing interoperable products and services necessary to revolutionize the standards of care supporting urologic oncology, including for prostate, bladder, and other urothelial cancers.
miR Scientific, LLC is a healthcare company committed to transforming global cancer management by providing early and highly accurate detection, characterization, and monitoring of disease. The Company has developed the miR Disease Management Platform®, a proprietary, non-invasive platform for the effective management of targeted diseases, initially focused on urological cancers. The platform is powered by the miR Sentinel® Prostate Cancer Test, a liquid biopsy urine test that can accurately detect, classify, and monitor prostate cancer based on the interrogation of small-non-coding RNAs extracted from urinary exosomes. miR Scientific is developing interoperable products and services necessary to revolutionize the standards of care supporting urologic oncology, including for prostate, bladder, and other urothelial cancers. Such new standards are urgently needed given the prevalence of these cancers and their debilitating burden globally. miR Scientific is a majority-owned operating subsidiary of Impact NRS LLC, headquartered in New York City with operating subsidiaries in Israel, Canada, and Puerto Rico.
miR Scientific, LLC on LinkedIn: #prostatecancer #urology #menshealth
Tahirah W. - St. John's University, The Peter J. Tobin College of Business - New York, New York, United States
miR Scientific, LLC on LinkedIn: We are redefining the standard of care to industry-leading level of…
miR Scientific announces FDA Breakthrough Device Designation for its Prostate Cancer Liquid Biopsy Test
Tim Neuman - Sr. Director, Diagnostic Genomics - Baylor Genetics
miR Scientific announces commercial launch of miR Sentinel
Perkin Elmer US LLC Polystyrene Test Film - MIR
Cells, Free Full-Text
miR Scientific, LLC Overview
IJMS, Free Full-Text
